⌕
ADMA Biologics · ADMA · Nasdaq
Tenet 67 · Solid
Compare
$13.68+3.32%At closeTenet 67 · Solid
$13.68+0.44 (+3.32%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

ADMA Biologics (ADMA) Stock

ADMA Biologics (ADMA) closed at $13.68 on Nov 13, 2026; its Tenet Score is 67 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$13.68
Nov 13, 2026
Market cap
$3.0B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
16.9×
price ÷ earnings
52-week range
7.21 – 20.46
low → high
Tenet Score
67/100
Solid · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Adma Biologics Inc scores 67/100. Solid. Strongest on quality and growth, trading at 17× earnings versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
67/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
60
Quality
73
Health
63
Growth
73

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityBHealthCGrowthBMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
6.9×
price to book value
P/S
5.8×
price to fiscal 2025 sales
ROE
42%
return on equity
Operating margin
37.5%
fiscal 2025, before interest and tax
Net margin
35.1%
of revenue kept
Current ratio
6.04
current assets to liabilities
Net debt / EBITDA
0.3×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Adma Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BI…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 113 US ETFs · top wrappers by weightSee all ETFs holding ADMA →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is ADMA Biologics in?

ADMA Biologics is in the Healthcare sector and the Drugs industry.

What is ADMA Biologics' Tenet Score?

ADMA Biologics' Tenet Score is 67 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.